On July 19-20, 2022, from 12-4pm (EST), the Newborn Screening Translational Research Network (NBSTRN) is excited to host its annual Network Meeting and is inviting you to spend two days, four sessions per day learning how successful researchers, advocates, and experts are leading the charge in advancements in Newborn Screening (NBS) and rare disease. Additionally, you will learn how NBSTRN has partnered with and contributed to the success of various projects related to NBS research with NBSTRN’s developed data tools, research and parental resources, and expert consultations. With the presentation of this meeting, NBSTRN seeks to expand its network by showcasing its various capabilities, facilitating advancements in both policy and research to advance NBS and how NBSTRN may facilitate your current or future NBS studies and projects, helping to save and improve upon the lives of newborns and children.
Each day, four sessions will highlight the latest research updates from our NBSTRN partners, stakeholders, CDC, and NICHD. You will have an opportunity to chat with our speakers during the live Q/A session. We will also introduce you to the NBSTRN team and conduct training sessions on NBSTRN tools and resources from 3 PM to 4 PM (EST).
This year, we will learn from speakers on the BabySeq2 Project (an implementation study of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants), Recommended Uniform Screening Panel (RUSP) alignment legislation, advocacy efforts on Krabbe and Cystic Fibrosis research, ED3N (a National Newborn Screening Data Platform developed by CDC), new screening efforts for early hearing detection, and research development in Congenital Cytomegalovirus (CMV).
NBSTRN 2022 Network Meeting speakers include the following:
*Both days will conclude with updates from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and NBSTRN
Register today at https://nbstrn.org/2022-Network-Meeting